These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 8643093

  • 1. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
    Mankhetkorn S, Dubru F, Hesschenbrouck J, Fiallo M, Garnier-Suillerot A.
    Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
    Bogush T, Robert J.
    Anticancer Res; 1996 Mar; 16(1):365-8. PubMed ID: 8615637
    [Abstract] [Full Text] [Related]

  • 3. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin.
    Evans CH, Baker PD.
    Cancer Res; 1992 Nov 01; 52(21):5893-9. PubMed ID: 1356622
    [Abstract] [Full Text] [Related]

  • 4. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S, Garnier-Suillerot A.
    Eur J Pharmacol; 1998 Feb 19; 343(2-3):313-21. PubMed ID: 9570481
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
    Zheng Z, Aojula H, Clarke D.
    J Drug Target; 2010 Jul 19; 18(6):477-87. PubMed ID: 20088680
    [Abstract] [Full Text] [Related]

  • 11. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL, Hirano T, Tanaka S, Onda K, Oka K.
    J Pharm Pharmacol; 2003 Nov 19; 55(11):1531-7. PubMed ID: 14713364
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of idarubicin and daunorubicin and their main metabolites regarding intracellular uptake and effect on sensitive and multidrug-resistant HL60 cells.
    Tidefelt U, Prenkert M, Paul C.
    Cancer Chemother Pharmacol; 1996 Nov 19; 38(5):476-80. PubMed ID: 8765443
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J, Hevér A, Fakla I, Fischer J, Ocsovski I, Aszalós A.
    Anticancer Res; 1997 Nov 19; 17(1A):481-6. PubMed ID: 9066699
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.